Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
Rom S LeidnerMarka CrittendenKristina YoungHong XiaoYaping WuMarcus A CoueyAshish A PatelAllen C ChengAmber L WattersCarlo BifulcoGeorge MorrisLessli RushforthShorin NemethWalter J UrbaMichael J GoughRichard B BellPublished in: Journal for immunotherapy of cancer (2022)
This study is registered with clinicaltrials.gov (NCT03247712) and is active, but closed to patient accrual.